Literature DB >> 6170429

Measurement of urinary beta 2-microglobulin in the detection of cisplatin nephrotoxicity.

A I Cohen, J Harberg, D L Citrin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170429

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  10 in total

Review 1.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.

Authors:  Blessy George; Melanie S Joy; Lauren M Aleksunes
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-12

3.  Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin.

Authors:  U Metz-Kurschel; E Kurschel; N Niederle; E Aulbert
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment.

Authors:  A S Tirelli; N Colombo; G Cavanna; C Mangioni; B M Assael
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide.

Authors:  C de Gislain; M Dumas; P d'Athis; J L Lautissier; A Escousse; J Guerrin
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion.

Authors:  J H Blom; K H Kurth; T A Splinter
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

7.  Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.

Authors:  M P Goren; A A Forastiere; R K Wright; M E Horowitz; R K Dodge; B A Kamen; M J Viar; C B Pratt
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  [The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)].

Authors:  T G Wendt; R Hartenstein; U Büll; K Schlechtweg; E A Moser
Journal:  Klin Wochenschr       Date:  1983-06-01

9.  Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

Authors:  G Daugaard; N Rossing; M Rørth
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?

Authors:  P G Sørensen; M H Nissen; S Groth; M Rørth
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.